Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Yifeng Pharmacy Chain Co's 3-Year RORE % for the quarter that ended in Jun. 2026 was 8.49%.
The industry rank for Yifeng Pharmacy Chain Co's 3-Year RORE % or its related term are showing as below:
SHSE:603939's 3-Year RORE % is ranked better than 56.59% of 599
companies
in the Healthcare Providers & Services industry
Industry Median: 0.91
vs SHSE:603939: 8.49
Yifeng Pharmacy Chain Co (SHSE:603939) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Yifeng Pharmacy Chain Co 3-Year RORE % Related Terms
Yifeng Pharmacy Chain Co 3-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yifeng Pharmacy Chain Co 3-Year RORE % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Yifeng Pharmacy Chain Co's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yifeng Pharmacy Chain Co 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yifeng Pharmacy Chain Co's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Yifeng Pharmacy Chain Co's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2026 and 3-year before.
Yifeng Pharmacy Chain Co (SHSE:603939) has a 3-Year RORE % of 8.49 as of Jun. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Yifeng Pharmacy Chain Co and its competitors. According to the industry distribution chart, Yifeng Pharmacy Chain Co ranks #260 out of 599 companies in the Healthcare Providers & Services industry, placing it in the top 43.4%.
Is Yifeng Pharmacy Chain Co's 3-Year RORE % too high?
Yifeng Pharmacy Chain Co's current 3-Year RORE % is 8.49. The Healthcare Providers & Services industry median 3-Year RORE % is 0.91. Yifeng Pharmacy Chain Co's value of 8.49 is 833% above this industry median. Based on the distribution chart, Yifeng Pharmacy Chain Co ranks #260 out of 599 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Yifeng Pharmacy Chain Co has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Yifeng Pharmacy Chain Co's 3-Year RORE % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Yifeng Pharmacy Chain Co ranks #260 out of 599 companies for 3-Year RORE %. This puts Yifeng Pharmacy Chain Co in the upper half of its industry. The industry median 3-Year RORE % is 0.91. Yifeng Pharmacy Chain Co's value of 8.49 is 833% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.91, based on 599 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yifeng Pharmacy Chain Co's current 3-Year RORE % of 8.49 is 833% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Yifeng Pharmacy Chain Co and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yifeng Pharmacy Chain Co's current 3-Year RORE % is 8.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yifeng Pharmacy Chain Co stock overvalued right now?
Based on GuruFocus' analysis, Yifeng Pharmacy Chain Co (SHSE:603939) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥26.22, compared to a current price of ¥22.56 — trading 14% below its estimated fair value. The current 3-Year RORE % is 8.49 and 833% above the Healthcare Providers & Services industry median of 0.91. Yifeng Pharmacy Chain Co's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Yifeng Pharmacy Chain Co (SHSE:603939), the current 3-Year RORE % is 8.49 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yifeng Pharmacy Chain Co (SHSE:603939) Overvalued in 2026?
Based on GuruFocus' analysis, Yifeng Pharmacy Chain Co stock appears to be undervalued.
The current stock price of ¥22.56 is trading 14% below its estimated GF Value™ of ¥26.22.
GuruFocus considers Yifeng Pharmacy Chain Co to be Modestly Undervalued.
Key valuation signals for SHSE:603939:
3-Year RORE %: 8.49
GF Value™: ¥26.22 vs. price of ¥22.56 (14% below fair value)
Industry Position: 833% above the Healthcare Providers & Services median (#260 of 599)
No single metric tells the full story. See the SHSE:603939 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yifeng Pharmacy Chain Co Ltd is mainly engaged in the chain retail business of medicines, health products, medical devices, and health-related daily convenience products. Its operating segments include the Retail segment and the Wholesale segment.
93GF Score
Get the complete analysis for SHSE:603939
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603939 has been successfully added to your 
